未登录

S

Songjiang Huang

Sichuan University

H指数:17

被引数:979

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hypoxia-activated cascade nanovaccine for synergistic chemoembolization-immune therapy of hepatocellular carcinoma

IF12.9

2024-04-014

PRE

The Added Value of Sarcopenia on Existing Risk Scores to Predict Mortality after TIPS Placement: A Multicenter Study

肌少症对现有风险评分预测TIPS置入后死亡率的附加值: 一项多中心研究

ACADEMIC RADIOLOGY

IF3.9

2023-09-015

PRE

Improvement of sarcopenia is beneficial for prognosis in cirrhotic patients after TIPS placement

DIGESTIVE AND LIVER DISEASE

IF3.8

2023-07-015

PRE

The impact of thrombocytopenia on variceal bleeding in cirrhotic patients with transjugular intrahepatic portosystemic shunt

SCIENTIFIC REPORTS

IF3.9

2023-01-302

OAAI

TIPS placement as the first-line therapy to prevent variceal rebleeding in patients with cirrhosis and sarcopenia

EUROPEAN JOURNAL OF RADIOLOGY

IF3.3

2023-01-017

OAAI

A VEGFR targeting peptide-drug conjugate (PDC) suppresses tumor angiogenesis in a TACE model for hepatocellular carcinoma therapy

CELL DEATH DISCOVERY

IF7

2022-10-0612

OAAI

Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement

IF15.2

2022-06-0159

PRE

Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination

经动脉化疗栓塞联合阿帕替尼和卡姆瑞珠单抗治疗不可切除的肝细胞癌的晚期疗效优于早期联合

IF3.4

2022-03-2722

OAAI

Microwave ablation combined with anti-PD-1 therapy enhances systemic antitumor immunity in a multitumor murine model of Hepa1-6

INTERNATIONAL JOURNAL OF HYPERTHERMIA

IF3

2022-02-0625

OA

Apatinib Plus Camrelizumab With/Without Chemoembolization for Hepatocellular Carcinoma: A Real-World Experience of a Single Center

阿帕替尼联合卡米瑞珠单抗加/不加化疗栓塞治疗肝细胞癌: 单中心的真实世界经验

FRONTIERS IN ONCOLOGY

IF3.3

2022-01-3143

OAAI

Development and Validation of Prognostic Models to Estimate the Risk of Overt Hepatic Encephalopathy After TIPS Creation: A Multicenter Study

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY

IF3

2022-01-2711

OAAI

Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization

JOURNAL OF HEPATOCELLULAR CARCINOMA

IF3.4

2021-12-012

OAAI

Liver fibrosis promotes immunity escape but limits the size of liver tumor in a rat orthotopic transplantation model

SCIENTIFIC REPORTS

IF3.9

2021-11-245

OAAI

Potential Benefits of Underdilation of 8-mm Covered Stent in Transjugular Intrahepatic Portosystemic Shunt Creation

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY

IF3

2021-06-0116

OAAI

Effect of splenectomy on the outcomes in patients with cirrhosis receiving transjugular intrahepatic portosystemic shunt

脾切除术对肝硬化患者经颈静脉肝内门体分流术预后的影响

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

IF3.4

2021-05-2012

OAAI

Myocardial injury and risk factors for mortality in patients with COVID-19 pneumonia

INTERNATIONAL JOURNAL OF CARDIOLOGY

IF3.2

2021-03-0132

OAAI

Effect of Inhibiting Tumor Angiogenesis After Embolization in the Treatment of HCC with Apatinib-Loaded p(N-Isopropyl-Acrylamide-co-Butyl Methyl Acrylate) Temperature-Sensitive Nanogel

JOURNAL OF HEPATOCELLULAR CARCINOMA

IF3.4

2020-12-0112

OAAI

Apatinib-loaded CalliSpheres Beads for embolization in a rabbit VX2 liver tumor: characterizationin vitro, pharmacokinetics and tumor responsein vivo

IF8.1

2020-09-1413

OAAI

Letter: does early transjugular intrahepatic porto-systemic shunt really have no effect on survival in high-risk patients with oesophageal variceal bleeding?

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2020-09-090

OAAI

Combining transcatheter arterial embolization with iodized oil containing Apatinib inhibits HCC growth and metastasis

SCIENTIFIC REPORTS

IF3.9

2020-02-1932

OAAI